AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2007
Mar 1, 2007
30339_dirs_2007-03-01_b0c90ee7-741b-44eb-8f19-b2ff1f08311c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2007-02-27
Reporting Person: LUZZI RICHARD D (VP, Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-02-27 | Common stocks | A | 4349 | $44.9700 | Acquired | 15513.0958 | Direct |
| 2007-02-27 | Common stocks | A | 1872.161 | $44.7700 | Acquired | 10884.1889 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2007-02-27 | Stock Option (Right to Buy) | $44.9700 | A | 11414 | Acquired | 2018-02-27 | Common Stock (11414.0000) | Direct |
Footnotes
F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2004 that have vested for performance period III.
F2: Bonus and incentive shares granted on 2/27/07.
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12